African trypanosomiasis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{African trypanosomiasis}} | {{African trypanosomiasis}} | ||
{{CMG}}; {{AOEIC}} Pilar Almonacid | {{CMG}}; {{AOEIC}} Pilar Almonacid , {{ADG}} | ||
==Overview== | |||
==EPidemiology and Demographics== | |||
===Incidence and prevalance=== | |||
* | |||
Revision as of 13:14, 26 June 2017
African trypanosomiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
African trypanosomiasis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of African trypanosomiasis epidemiology and demographics |
FDA on African trypanosomiasis epidemiology and demographics |
CDC on African trypanosomiasis epidemiology and demographics |
African trypanosomiasis epidemiology and demographics in the news |
Blogs on African trypanosomiasis epidemiology and demographics |
Risk calculators and risk factors for African trypanosomiasis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Pilar Almonacid , Aditya Ganti M.B.B.S. [2]
Overview
EPidemiology and Demographics
Incidence and prevalance